CC BY-NC-ND 4.0 · Indian Journal of Medical and Paediatric Oncology 2021; 42(01): 093-095
DOI: 10.1055/s-0041-1729727
Trainees’ Corner

Nanotechnology in Oncology

Srujana Joga
1  Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India
,
V. P.B. Koyyala
2  Department of Medical Oncology, Homi Bhabha Cancer Hospital and Research Centre, Visakhapatnam, Andhra Pradesh, India
› Author Affiliations

Almost all chemotherapy agents act on healthy tissues along with cancerous tissues, resulting in the adverse effects and suboptimal doses to the tumor sites. The advent of nanotechnology in medicine enabled us to encapsulate the drugs with a nano-sized particle, thereby delivering these drugs with high precision to the tumor site. This technology has opened a new vista of opportunities in clinical medicine, Medical Oncology in particular.

Richard Feynman way back in 1959 mentioned in his famous lecture and advised the scientific community to think small for future innovations in science. This laid foundation stone to a new era in science and technology that is today’s nanotechnology. The term “Nano” literally means a dwarf in the Greek language.[1] Nanotechnology is a branch of science dealing with particles ranging from the size between one and one thousand nanometers. Nanomedicine is a subspecialty of nanotechnology exploring its applications in the medical field.[2]



Publication History

Publication Date:
22 May 2021 (online)

© 2021. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India